Profil bibliographique

Tristan M. Sissung

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

283Publications signalées

4415Citations signalées

3Affiliations récentes

Institutions déclarées

National Institutes of Health National Cancer Institute Center for Cancer Research

Domaines associés

Prostate Cancer Treatment and ResearchChronic Myeloid Leukemia TreatmentsPARP inhibition in cancer therapyCancer therapeutics and mechanismsDrug Transport and Resistance Mechanisms

Publications récentes

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S4 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Data S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S2 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S3 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S2 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2025 articleOpenAlex

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival

Morgan Similuk, Sarah A. Bannon, Jia Yan, Rajarshi Ghosh et autres

1 citationTransplantation

Accès ouvert 2024 articleOpenAlex

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study

Ilana Schlam, Dylan M. Smith, Cody Peer, Tristan M. Sissung et autres

1 citationnpj Breast Cancer

Accès ouvert 2024 supplementary-materialsOpenAlex

Supplementary Figure S4 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2024 supplementary-materialsOpenAlex

Supplementary Figure S2 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Accès ouvert 2024 supplementary-materialsOpenAlex

Supplementary Data S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.